Huimin Bian

687 citations
19 papers · 564 indexed · h-index 11

Huimin Bian

19 papers receiving 561 citations

Peers

Huimin Bian
Comparison fields: 5 of 85
  • Pharmacology 203
  • Complementary and alternative medicine 61
  • Biochemistry 39
  • Cancer Research 79
  • Pharmacology 43
Replace Xu Zheng with:
Xu Zheng China
Marietta Kaszkin Germany
Haiming Ding United States
Yoshimi Aizaki Japan
Dinesh Thapa South Korea
Ga Young You South Korea
Elena Darra Italy
Chengzhi Xie China
Ling He China
Huimin Bian relative to Xu Zheng China Xu Zheng's profile →
Citations per field
00.5×2.8×
Xu Zheng · 1×
Citations per year

Countries citing papers authored by Huimin Bian

Since Specialization
Citations

This map shows the geographic impact of Huimin Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huimin Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huimin Bian more than expected).

Fields of papers citing papers by Huimin Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huimin Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huimin Bian. The network helps show where Huimin Bian may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Huimin Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Huimin Bian Line = papers co-authored together Huimin Bian links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1 20247
2 20242
3 202313
4 20229
5 202118
6 20216
7 20203
8 201826
9 201815
10 201735
11 201614
12 201646
13 201665
14
Effect of Liuwei Dihuang Formula and its compatibility on rats with ovariectomy-induced atherosclerosis
20161
15 201435
16 20144
17 201325
18
[Effects and mechanism of five Chinese patent medicines on focal cerebral ischemia].
20112
19 2001238

About Huimin Bian

Huimin Bian is a scholar working on Complementary and alternative medicine, Pharmacology and Behavioral Neuroscience, having authored 19 papers that have together received 564 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (5 papers), Estrogen and related hormone effects (3 papers), Advanced Breast Cancer Therapies (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Cholesterol and Lipid Metabolism (2 papers), Cardiac Fibrosis and Remodeling (2 papers), Peptidase Inhibition and Analysis (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). The work is most often cited by research in Pharmacology (203 citations), Complementary and alternative medicine (61 citations) and Biochemistry (39 citations). Huimin Bian has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Dirk O. Stichtenoth, Per‐Johan Jakobsson, Staffan Thorén, Marc Peters‐Golden, Leslie J. Crofford, Qichun Zhang, Chao Lin, Xin Sun, Zhi Ma and Yue Zhao. Their work appears in journals such as The Journal of Immunology, Cancer Research and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026